Cargando…
Pharmacological treatments in ARDS; a state-of-the-art update
Despite its high incidence and devastating outcomes, acute respiratory distress syndrome (ARDS) has no specific treatment, with effective therapy currently limited to minimizing potentially harmful ventilation and avoiding a positive fluid balance. Many pharmacological therapies have been investigat...
Autores principales: | Boyle, Andrew James, Sweeney, Rob Mac, McAuley, Daniel Francis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765621/ https://www.ncbi.nlm.nih.gov/pubmed/23957905 http://dx.doi.org/10.1186/1741-7015-11-166 |
Ejemplares similares
-
Do Nonventilatory Strategies for Acute Lung Injury and ARDS Work?
por: Sweeney, Rob Mac, et al.
Publicado: (2010) -
Emerging pharmacological therapies for ARDS: COVID-19 and beyond
por: Horie, Shahd, et al.
Publicado: (2020) -
Acute respiratory distress syndrome
por: Sweeney, Rob Mac, et al.
Publicado: (2016) -
Cytokine adsorption during ECMO for COVID-19-related ARDS
por: Shekar, Kiran, et al.
Publicado: (2021) -
Hyperoxaemia and hypoxaemia are associated with harm in patients with ARDS
por: Boyle, Andrew J., et al.
Publicado: (2021)